New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.

After surgery and chemotherapy failed to eliminate his colon cancer four years ago, Mr Story joined a clinical trial for a highly experimental treatment: fecal transplant. He was to be given a ...

A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously ...

A real-world study of patients with Clostridioides difficile infection (CDI) in Australia over 10 years shows that fecal ...

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative ...

Scientists develop a synthetic microbiome therapy to fight C. difficile infections offering a safer, targeted alternative ...

Since the FDA’s approval of the first fecal transplant pills in 2023, many experts are hopeful that adapting it and similar innovations could help treat particularly resistant cancers.